Intrinsiqs

Is Enovis Corporation overvalued?

Enovis Corporation (ENOV) looks undervalued — trading about 126% below its fair value.

Undervalued
Current price $27.68 Fair value $62.46
Price
$27.68
Fair value
$62.46
Current P/E
8.2
Normal P/E
18.5
Market cap
$1.60B
Dividend yield
0.0%
Return on equity
-35.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ENOV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.